ALDX R&D Expenses
Aldeyra Therapeutics Inc · R&D Expenses
ALDX R&D Expenses
Latest reported$3.48Mperiod ending
ALDX Quarterly R&D Expenses ($96.17K → $3.48M)
Quarterly R&D Expenses
High-resolution chart · PNG
ALDX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 3,484,514 | |
| 2,409,575 | |
| 4,303,546 | |
| 5,430,757 | |
| 8,505,229 | |
| 7,423,324 | |
| 14,630,032 | |
| 12,441,509 | |
| 14,969,743 | |
| 6,183,508 | |
| 4,298,282 | |
| 6,961,669 | |
| 6,962,907 | |
| 11,235,861 | |
| 8,961,472 | |
| 11,539,620 | |
| 14,570,654 | |
| 12,234,320 | |
| 12,841,400 | |
| 12,894,344 | |
| 11,474,446 | |
| 7,726,342 | |
| 7,028,243 | |
| 6,133,580 | |
| 4,885,875 | |
| 6,633,603 | |
| 9,614,431 | |
| 16,223,972 | |
| 10,664,858 | |
| 7,848,590 | |
| 8,548,975 | |
| 7,880,822 | |
| 6,792,974 | |
| 6,600,106 | |
| 5,545,289 | |
| 3,539,368 | |
| 3,848,889 | |
| 3,369,023 | |
| 3,447,176 | |
| 3,379,711 | |
| 2,834,523 | |
| 3,511,477 | |
| 3,112,457 | |
| 2,076,410 | |
| 1,249,097 | |
| 1,136,434 | |
| 1,403,690 | |
| 1,195,668 | |
| 663,908 | |
| 444,278 | |
| 400,358 | |
| 666,040 | |
| 325,050 | |
| 150,233 | |
| 96,167 |